ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Pfenex
12.75
+0.0000
成交量:
- -
成交额:
- -
市值:
4.37亿
市盈率:
-70.90
高:
12.75
开:
12.75
低:
12.75
收:
12.75
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
Pfenex
交易所:
AMEX
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.pfenex.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Pfenex Inc.是于2009年在特拉华州注册成立。公司是一个临床阶段的生物技术公司,从事开发制造高难度和高价值的蛋白质,最初集中在生物仿制药或生物疗法。pfenex领先的候选产品是pf582,一个生物仿制药的候选人Lucentis(ranibizumab)。对此,销售由瑞士巴塞尔豪夫迈·罗氏有限公司和诺华公司,为视网膜疾病的治疗,2014年全球产品销售取得了约45亿美元。为pf582,公司目前正在进行1b/2a阶段试验在湿性年龄相关性黄斑变性患者,或湿AMD,结果将于2014第四季度。该公司预计将在2015年结果预计在2017的3期临床试验。它打算将pf582自己内部的销售和市场营销在北美国和欧洲的能力。pfenex的下一个最先进的产品候选人pf530,一个生物仿制药的候选重组干扰素β-1b(干扰素β-1b),销售由拜耳公司用于治疗多发性硬化症和全球产品销售在2015达到超过9亿美元。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PFNX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFNX\",,,,,undefined,":{"symbol":"PFNX","market":"US","secType":"STK","nameCN":"Pfenex","latestPrice":12.75,"timestamp":1601582400000,"preClose":12.75,"halted":4,"volume":0,"delay":0,"floatShares":31151972,"shares":34296593,"eps":-0.179841,"marketStatus":"退市","change":0,"latestTime":"05-09 08:57:41 EDT","open":12.75,"high":12.75,"low":12.75,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.179841,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746797400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1406174400000,"exchange":"AMEX","adjPreClose":12.75,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFNX\",,,,,undefined,":{"symbol":"PFNX","floatShares":31151972,"roa":"-4.95%","roe":"-9.22%","lyrEps":0.033478,"shares":34296593,"dividePrice":0,"high":12.75,"amplitude":0,"preClose":12.75,"low":12.75,"week52Low":5.26,"pbRate":"5.92","week52High":14,"institutionHeld":0,"latestPrice":12.75,"eps":-0.179841,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.179841,"open":12.75},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pfenex.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":0.1381},{"period":"3month","weight":-0.0594},{"period":"6month","weight":-0.0554},{"period":"1year","weight":0.0926},{"period":"ytd","weight":-0.0359}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pfenex Inc.是于2009年在特拉华州注册成立。公司是一个临床阶段的生物技术公司,从事开发制造高难度和高价值的蛋白质,最初集中在生物仿制药或生物疗法。pfenex领先的候选产品是pf582,一个生物仿制药的候选人Lucentis(ranibizumab)。对此,销售由瑞士巴塞尔豪夫迈·罗氏有限公司和诺华公司,为视网膜疾病的治疗,2014年全球产品销售取得了约45亿美元。为pf582,公司目前正在进行1b/2a阶段试验在湿性年龄相关性黄斑变性患者,或湿AMD,结果将于2014第四季度。该公司预计将在2015年结果预计在2017的3期临床试验。它打算将pf582自己内部的销售和市场营销在北美国和欧洲的能力。pfenex的下一个最先进的产品候选人pf530,一个生物仿制药的候选重组干扰素β-1b(干扰素β-1b),销售由拜耳公司用于治疗多发性硬化症和全球产品销售在2015达到超过9亿美元。","exchange":"AMEX","name":"Pfenex","nameEN":"Pfenex"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PFNX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-01","symbol":"PFNX","reason":null,"defaultRemindTime":1601559000000,"announcedDate":"2020-09-30","type":"delisting","dateTimestamp":1601524800000},{"market":"US","date":"2020-08-06","symbol":"PFNX","fiscalQuarterEnding":"2020/06","expectedEps":-0.27,"name":null,"time":"盘后","type":"earning","dateTimestamp":1596686400000,"reportTimeType":"post","actualEps":-0.3},{"date":"2020-05-07","symbol":"PFNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2020/03","expectedEps":-0.26,"defaultRemindTime":1588881600000,"name":null,"time":"盘后","dateTimestamp":1588824000000,"actualEps":null},{"market":"US","date":"2020-03-11","symbol":"PFNX","fiscalQuarterEnding":"2019/12","expectedEps":0.24,"name":null,"time":"盘后","type":"earning","dateTimestamp":1583899200000,"reportTimeType":"post","actualEps":0.29},{"market":"US","date":"2019-11-07","symbol":"PFNX","fiscalQuarterEnding":"2019/09","expectedEps":0.09,"name":null,"time":"盘后","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"post","actualEps":0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFNX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFNX","date":"2020-09-30","current":-75.504577,"percent":0.342857,"low":-110.163438,"twenty":-92.085335,"median":-14.688423,"eighty":-10.720523,"high":313.906954,"avg":-2.60925,"sd":99.098569,"marketCap":437624526},"quantilePoints":[{"date":"2020-05-15","current":-74.007233,"twenty":-72.312411,"median":-12.331308,"eighty":-9.242258,"marketCap":224611951},{"date":"2020-05-22","current":-77.622853,"twenty":-76.154007,"median":-12.418394,"eighty":-9.267103,"marketCap":235585359},{"date":"2020-05-29","current":-82.594331,"twenty":-77.645451,"median":-12.471768,"eighty":-9.505613,"marketCap":250673796},{"date":"2020-06-05","current":-91.633383,"twenty":-78.752734,"median":-12.609982,"eighty":-9.674558,"marketCap":278107317},{"date":"2020-06-12","current":-102.254268,"twenty":-85.170461,"median":-12.737707,"eighty":-9.711825,"marketCap":310341704},{"date":"2020-06-19","current":-90.61649,"twenty":-91.723773,"median":-12.935101,"eighty":-9.833564,"marketCap":275021046},{"date":"2020-06-26","current":-89.93856,"twenty":-96.469275,"median":-12.987353,"eighty":-9.877718,"marketCap":272963531},{"date":"2020-07-02","current":-94.006134,"twenty":-95.972128,"median":-13.120884,"eighty":-10.097275,"marketCap":285308616},{"date":"2020-07-10","current":-90.503501,"twenty":-95.361991,"median":-13.132495,"eighty":-10.366659,"marketCap":274678127},{"date":"2020-07-17","current":-91.520395,"twenty":-94.661465,"median":-13.21958,"eighty":-10.470803,"marketCap":277764398},{"date":"2020-07-24","current":-88.469715,"twenty":-94.14172,"median":-13.3415,"eighty":-10.484856,"marketCap":268505584},{"date":"2020-07-31","current":-82.255367,"twenty":-94.006134,"median":-13.411169,"eighty":-10.519929,"marketCap":249645039},{"date":"2020-08-07","current":-83.837201,"twenty":-93.870548,"median":-13.434391,"eighty":-10.55268,"marketCap":254445905},{"date":"2020-08-14","current":-75.741268,"twenty":-93.576779,"median":-13.753705,"eighty":-10.566485,"marketCap":438996390},{"date":"2020-08-21","current":-74.557811,"twenty":-93.3734,"median":-13.980127,"eighty":-10.596274,"marketCap":432137071},{"date":"2020-08-28","current":-74.202774,"twenty":-93.328205,"median":-14.293635,"eighty":-10.619788,"marketCap":430079276},{"date":"2020-09-04","current":-76.214651,"twenty":-93.124827,"median":-14.374915,"eighty":-10.629912,"marketCap":441740117},{"date":"2020-09-11","current":-75.208712,"twenty":-92.853655,"median":-14.444583,"eighty":-10.648473,"marketCap":435909697},{"date":"2020-09-18","current":-75.14954,"twenty":-92.469495,"median":-14.531669,"eighty":-10.68574,"marketCap":435566731},{"date":"2020-09-25","current":-75.090367,"twenty":-92.153128,"median":-14.6652,"eighty":-10.713069,"marketCap":435223765},{"date":"2020-09-30","current":-75.504577,"twenty":-92.085335,"median":-14.688423,"eighty":-10.720523,"marketCap":437624526}],"updateTime":1746792765492}}}